Antimycobacterial activity of usnic acid against resistant and susceptible strains of Mycobacterium tuberculosis and non-tuberculous mycobacteria

Pharm Biol. 2010 Mar;48(3):260-3. doi: 10.3109/13880200903085490.

Abstract

Tuberculosis remains a serious public health problem, with nine million cases being reported annually. Treatment with antibiotics is the most effective mechanism to control this disease, although the increase in cases with resistant strains, co-infection with HIV, and the long duration of treatment has established the need to develop new drugs. Here we show the activity of usnic acid against susceptible and resistant Mycobacterium tuberculosis strains and against nontuberculous mycobacteria. Further, we did not identify any contribution of efflux in innate resistance to usnic acid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacokinetics
  • Anti-Bacterial Agents / pharmacology*
  • Benzofurans / pharmacokinetics
  • Benzofurans / pharmacology*
  • Calcium Channel Blockers / pharmacology
  • Carbonyl Cyanide m-Chlorophenyl Hydrazone / pharmacology
  • Drug Evaluation, Preclinical
  • Drug Resistance, Bacterial / drug effects
  • Drug Resistance, Bacterial / genetics*
  • Ionophores / pharmacology
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / genetics*
  • Nontuberculous Mycobacteria / drug effects*
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Verapamil / pharmacology

Substances

  • Anti-Bacterial Agents
  • Benzofurans
  • Calcium Channel Blockers
  • Ionophores
  • usnic acid
  • Carbonyl Cyanide m-Chlorophenyl Hydrazone
  • Verapamil